<?xml version="1.0" encoding="ISO-8859-1" ?>
<rss version="2.0">
<channel>
<title>newratings.com</title>
<link>www.newratings.com</link>
<description>newratings.com</description>
<language>en</language>
<copyright>newratings.com</copyright>
<lastBuildDate>Mon, 06 Jul 2009 04:07:00 +0200</lastBuildDate>
<ttl>2</ttl>



<item>
<title>Lanxess upgraded to "buy"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934488</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934488</guid>
<description>LONDON, July 3 (newratings.com) - Analysts at Deutsche Bank upgrade Lanxess AG (ticker: LXS) from "hold" to "buy." The target price has been raised from &#8364;16 to &#8364;25. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934488&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Philips "hold," target price raised</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934479</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934479</guid>
<description>LONDON, July 3 (newratings.com) - Analysts at Deutsche Bank maintain their "hold" rating on Philips (ticker: PHI1). The target price has been raised from &#8364;12 to &#8364;14. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934479&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Communisis "hold," target price reduced</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934472</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934472</guid>
<description>LONDON, July 3 (newratings.com) - Analysts at Panmure Gordon maintain their "hold" rating on Communisis Plc (ticker: CMS.L). The target price has been reduced from 32p to 26p. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934472&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Gran Tierra Energy initiated with "neutral"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934099</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934099</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at JP Morgan initiate coverage of Gran Tierra Energy (ticker: GTE) with a "neutral" rating. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934099&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>EZchip Semiconductor initiated with "hold"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934098</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934098</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Jefferies &amp; Co initiate coverage of EZchip Semiconductor Limited (ticker: EZCH) with a "hold" rating. The target price is set to $18. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934098&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>ONYX Pharmaceuticals initiated with "outperform"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934097</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934097</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Robert W Baird initiate coverage of ONYX Pharmaceuticals Inc (ticker: ONXX) with an "outperform" rating. The target price is set to $40. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934097&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>F5 Networks initiated with "hold"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934093</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934093</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Deutsche Bank Securities initiate coverage of F5 Networks Inc (ticker: FFIV) with a "hold" rating. The target price is set to $37. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934093&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Cisco Systems initiated with "buy"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934091</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934091</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Deutsche Bank Securities initiate coverage of Cisco Systems (ticker: CSCO) with a "buy" rating. The target price is set to $26. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934091&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Netflix reinitiated with "buy"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934089</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934089</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Stifel Nicolaus &amp; Company reinitiate coverage of Netflix Inc (ticker: NFLX) with a "buy" rating. The target price is set to $53. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934089&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Kennametal reinitiated with "underperform"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934087</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934087</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at JP Morgan reinitiate coverage of Kennametal (ticker: KMT) with an "underperform" rating. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934087&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Illumina "overweight," target price reduced</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934086</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934086</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Barclays Capital reiterate their "overweight" rating on Illumina (ticker: ILMN). The target price has been reduced from $46 to $42. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934086&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Ceragon Networks "equal weight," target price raised</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934085</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934085</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Barclays Capital reiterate their "equal weight" rating on Ceragon Networks Ltd. (ticker: CRNT). The target price has been raised from $4 to $6.50. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934085&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>International Paper "buy," target price raised</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934083</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934083</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at UBS reiterate their "buy" rating on International Paper (ticker: IP). The target price has been raised from $18 to $21. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934083&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Aryx Therapeutics "buy," target price raised</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934082</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934082</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Wedbush Morgan reiterate their "buy" rating on Aryx Therapeutics (ticker: ARYX). The target price has been raised from $7.50 to $8. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934082&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>ADTRAN upgraded to "buy"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934081</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934081</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Citigroup upgrade ADTRAN (ticker: ADTN) from "hold" to "buy." [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934081&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Omnicom "neutral," target price raised</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934080</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934080</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Credit Suisse reiterate their "neutral" rating on Omnicom (ticker: OMC). The target price has been raised from $28 to $35. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934080&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Illumina "buy," target price reduced</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934079</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934079</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Wedbush Morgan reiterate their "buy" rating on Illumina Inc (ticker: ILMN). The target price has been reduced from $44 to $39. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934079&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>General Mills "outperform," target price raised</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934078</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934078</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Credit Suisse reiterate their "outperform" rating on General Mills (ticker: GIS). The target price has been raised from $62 to $68. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934078&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Take-Two upgraded to "buy"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934077</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934077</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Kaufman Bros upgrade Take-Two (ticker: TTWO) from "hold" to "buy." The target price has been raised from $8 to $14. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934077&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>BJ Services upgraded to "neutral"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934076</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934076</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at JP Morgan upgrade BJ Services (ticker: BJ) from "underweight" to "neutral." [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934076&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Sunpower upgraded to "neutral"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934074</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934074</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at JP Morgan upgrade Sunpower (ticker: SPWRA) from "underweight" to "neutral." [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934074&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Ascent Solar upgraded to "neutral"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934071</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934071</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at JP Morgan upgrade Ascent Solar (ticker: ASTI) from "underweight" to "neutral." [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934071&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Ball "buy," target price raised</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934070</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934070</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at KeyBanc Capital Markets reiterate their "buy" rating on Ball Corp (ticker: BLL). The target price has been raised from $48 to $55. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934070&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Evergreen Solar upgraded to "neutral"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934069</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934069</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at JP Morgan upgrade Evergreen Solar (ticker: ESLR) from "underweight" to "neutral." [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934069&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Acorda Therapeutics upgraded to "outperform"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934068</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934068</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Leerink Swann &amp; Co upgrade Acorda Therapeutics (ticker: ACOR) from "underperform" to "outperform." The target price has been raised from $15 to $30. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934068&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Mechel Steel upgraded to "neutral"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934067</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934067</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Credit Suisse upgrade Mechel Steel (ticker: MTL) from "underperform" to "neutral." [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934067&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Tata Motors upgraded to "buy"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934065</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934065</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Deutsche Bank Securities upgrade Tata Motors (ticker: TTM) from "hold" to "buy." [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934065&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>EXFO upgraded to "overweight"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934063</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934063</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Thomas Weisel upgrade EXFO (ticker: EXFO) from "market weight" to "overweight." The target price is set to $4. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934063&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Sepracor downgraded to "hold"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934062</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934062</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Deutsche Bank Securities downgrade Sepracor (ticker: SEPR) from "buy" to "hold." The target price is set to $16. [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934062&#034;&gt;more&lt;/a&gt;]</description>
</item>


<item>
<title>Discovery Laboratories downgraded to "sell"</title>
<link>http://www.newratings.com/en/main/company_headline.m?id=1934061</link>
<guid>http://www.newratings.com/en/main/company_headline.m?id=1934061</guid>
<description>NEW YORK, July 2 (newratings.com) - Analysts at Wedbush Morgan downgrade Discovery Laboratories (ticker: DSCO) from "hold" to "sell." [&lt;a href=&#034;http://www.newratings.com/en/main/company_headline.m?id=1934061&#034;&gt;more&lt;/a&gt;]</description>
</item>

</channel>
</rss>





